Pathkey.ai Ltd (AU:PKY) — Market Cap & Net Worth
Market Cap & Net Worth: Pathkey.ai Ltd (PKY)
Pathkey.ai Ltd (AU:PKY) has a market capitalization of $206.45 (AU$291.77) as of September 18, 2026. Listed on the AU stock exchange, this Australia-based company holds position #31997 globally and #1841 in its home market, demonstrating a -11.43% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pathkey.ai Ltd's stock price AU$0.03 by its total outstanding shares 9412 (9.41K). Also see PKY total asset value for a full breakdown of the balance sheet.
Pathkey.ai Ltd Market Cap History: 2025 to 2026
Pathkey.ai Ltd's market capitalization history from 2025 to 2026. Data shows growth from $106.55 to $206.45 (0.00% CAGR). Also see Pathkey.ai Ltd operating cash flow efficiency for how efficiently the company converts equity into cash flow.
Pathkey.ai Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pathkey.ai Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Pathkey.ai Ltd (PKY) share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
Pathkey.ai Ltd's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2025 | $106.55 | $27.78K | -$1.45 Million | 0.00x | N/A |
Competitor Companies of PKY by Market Capitalization
Companies near Pathkey.ai Ltd in the global market cap rankings as of September 18, 2026. Review PKY goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Pathkey.ai Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #736 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1884 globally with a market cap of $12.51 Billion USD ( AU$17.68 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2072 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2147 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #736 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $263.75 |
| #1884 | Pro Medicus Ltd | AU:PME | $12.51 Billion | AU$169.22 |
| #2072 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $80.36 |
| #2147 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $56.60 |
Pathkey.ai Ltd Historical Marketcap From 2025 to 2026
Between 2025 and today, Pathkey.ai Ltd's market cap moved from $106.55 to $ 206.45, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$206.45 | +93.75% |
| 2025 | AU$106.55 | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of Pathkey.ai Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $206.45 USD |
| MoneyControl | $206.45 USD |
| MarketWatch | $206.45 USD |
| marketcap.company | $206.45 USD |
| Reuters | $206.45 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pathkey.ai Ltd
Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The com… Read more